BRITTANY NIELSEN: Open Payments
NPI 1093299679 · PARKER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$739 in 32 payments from 17 companies in 2025. Trend: 2023 $88 · 2024 $345 · 2025 $739
Food & beverage: $739
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $147 |
| ABBVIE INC. | 5 | $85 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $59 |
| Corium, LLC | 3 | $57 |
| Tris Pharma Inc | 2 | $48 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Vertical Pharmaceuticals, LLC | 2 | $37 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 2 | $31 |
Products named: VRAYLAR, REXULTI, CAPLYTA, Azstarys, Auvelity, Relexxii, MOUNJARO, Dyanavel XR.
Industry payments across CO — which companies pay providers there.
